trial · primary record
18F-fluciclovine
Advanced Prostate Cancer
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2028-09-01 |
| Primary endpoint | Fluciclovine and PSMA Uptake in PSMA Positive Tumors |
| Registry ID | NCT06062745 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:34:22.596Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06062745
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.